Clinical perspectives on HIV-associated lipodystrophy syndrome: an update
- 1 October 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (15), 1917-1930
- https://doi.org/10.1097/00002030-200110190-00003
Abstract
No abstract availableThis publication has 92 references indexed in Scilit:
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imagingThe American Journal of Clinical Nutrition, 1999
- Lipodystrophy in patients naive to HIV protease inhibitorsAIDS, 1999
- Studies of Body Composition and Fat Distribution in HIV-Infected and Control SubjectsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999
- Body Shape Changes in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- “Buffalo hump” in HIV-1 infectionThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998